Our data, therefore, provide evidence for a role of CD73/ecto-5’ nucleotidase in immune modulation and provide the preclinical rationale for therapeutic targeting of CD73-mediated adenosine pathway to enhance tumor cytotoxicity and improve patient outcome in MM. The gene discussed is NT5E; the disease is neoplasm.